Bachmann CM, Janitschke D, Lauer AA, Erhardt T, Hartmann T, Grimm MOW, Grimm HS. Gemfibrozil-Induced Intracellular Triglyceride Increase in SH-SY5Y, HEK and Calu-3 Cells. Int J Mol Sci. 2023 Feb 3;24(3):2972. doi: 10.3390/ijms24032972. PMID: 36769295; PMCID: PMC9917468.

Lauer AA, Nguyen VTT, Janitschke D, Dos Santos Guilherme M, Bachmann CM, Grimm HS, Hartmann T, Endres K, Grimm MOW. The Influence of Acitretin on Brain Lipidomics in Adolescent Mice-Implications for Pediatric and Adolescent Dermatological Therapy. Int J Mol Sci. 2022 Dec 8;23(24):15535. doi: 10.3390/ijms232415535. PMID: 36555176; PMCID: PMC9778912.

Ablinger I, Dressel K, Rott T, Lauer AA, Tiemann M, Batista JP, Taddey T, Grimm HS, Grimm MOW. Interdisciplinary Approaches to Deal with Alzheimer’s Disease-From Bench to Bedside: What Feasible Options Do Already Exist Today? Biomedicines. 2022 Nov 14;10(11):2922. doi: 10.3390/biomedicines10112922. PMID: 36428494; PMCID: PMC9687885.

Theiss EL, Griebsch LV, Lauer AA, Janitschke D, Erhardt VKJ, Haas EC, Kuppler KN, Radermacher J, Walzer O, Portius D, Grimm HS, Hartmann T, Grimm MOW. Vitamin B12 Attenuates Changes in Phospholipid Levels Related to Oxidative Stress in SH-SY5Y Cells. Cells. 2022 Aug 18;11(16):2574. doi: 10.3390/cells11162574. PMID: 36010649; PMCID: PMC9406929.

Lyschik S, Lauer AA, Roth T, Janitschke D, Hollander M, Will T, Hartmann T, Kopito RR, Helms V, Grimm MOW, Schrul B. PEX19 Coordinates Neutral Lipid Storage in Cells in a Peroxisome-Independent Fashion. Front Cell Dev Biol. 2022 Apr 26;10:859052. doi: 10.3389/fcell.2022.859052. PMID: 35557938; PMCID: PMC9086359.

Janitschke D, Lauer AA, Bachmann CM, Winkler J, Griebsch LV, Pilz SM, Theiss EL, Grimm HS, Hartmann T, Grimm MOW. Methylxanthines Induce a Change in the AD/Neurodegeneration-Linked Lipid Profile in Neuroblastoma Cells. Int J Mol Sci. 2022 Feb 18;23(4):2295. doi: 10.3390/ijms23042295. PMID: 35216410; PMCID: PMC8875332.

Lauer AA, Grimm HS, Apel B, Golobrodska N, Kruse L, Ratanski E, Schulten N, Schwarze L, Slawik T, Sperlich S, Vohla A, Grimm MOW. Mechanistic Link between Vitamin B12 and Alzheimer’s Disease. Biomolecules. 2022 Jan 14;12(1):129. doi: 10.3390/biom12010129. PMID: 35053277; PMCID: PMC8774227.

Mett J, Lauer AA, Janitschke D, Griebsch LV, Theiss EL, Grimm HS, Koivisto H, Tanila H, Hartmann T, Grimm MOW. Medium-Chain Length Fatty Acids Enhance Aβ Degradation by Affecting Insulin-Degrading Enzyme. Cells. 2021 Oct 29;10(11):2941. doi: 10.3390/cells10112941. PMID: 34831163; PMCID: PMC8616162.

Lauer AA, Griebsch LV, Pilz SM, Janitschke D, Theiss EL, Reichrath J, Herr C, Beisswenger C, Bals R, Valencak TG, Portius D, Grimm HS, Hartmann T, Grimm MOW. Impact of Vitamin D₃ Deficiency on Phosphatidylcholine-/Ethanolamine, Plasmalogen-, Lyso-Phosphatidylcholine-/Ethanolamine, Carnitine- and Triacyl Glyceride-Homeostasis in Neuroblastoma Cells and Murine Brain. Biomolecules. 2021 Nov 15;11(11):1699. doi: 10.3390/biom11111699. PMID: 34827697; PMCID: PMC8615687.

Kurokin I, Lauer AA, Janitschke D, Winkler J, Theiss EL, Griebsch LV, Pilz SM, Matschke V, van der Laan M, Grimm HS, Hartmann T, Grimm MOW. Targeted Lipidomics of Mitochondria in a Cellular Alzheimer’s Disease Model. Biomedicines. 2021 Aug 21;9(8):1062. doi: 10.3390/biomedicines9081062. PMID: 34440266; PMCID: PMC8393816.

Lauer AA, Janitschke D, Dos Santos Guilherme M, Nguyen VTT, Bachmann CM, Qiao S, Schrul B, Boehm U, Grimm HS, Hartmann T, Endres K, Grimm MOW. Shotgun lipidomics of liver and brain tissue of Alzheimer’s disease model mice treated with acitretin. Sci Rep. 2021 Jul 27;11(1):15301. doi: 10.1038/s41598-021-94706-3. PMID: 34315969; PMCID: PMC8316403.

Rosenberg A, Solomon A, Soininen H, Visser PJ, Blennow K, Hartmann T, Kivipelto M; LipiDiDiet clinical study group. Research diagnostic criteria for Alzheimer’s disease: findings from the LipiDiDiet randomized controlled trial. Alzheimers Res Ther. 2021 Mar 25;13(1):64. doi: 10.1186/s13195-021-00799-3. PMID: 33766132; PMCID: PMC7995792.

Ramesh G, Jarzembowski L, Schwarz Y, Poth V, Konrad M, Knapp ML, Schwär G, Lauer AA, Grimm MOW, Alansary D, Bruns D, Niemeyer BA. A short isoform of STIM1 confers frequency-dependent synaptic enhancement. Cell Rep. 2021 Mar 16;34(11):108844. doi: 10.1016/j.celrep.2021.108844. PMID: 33730587.

Janitschke D, Lauer AA, Bachmann CM, Grimm HS, Hartmann T, Grimm MOW. Methylxanthines and Neurodegenerative Diseases: An Update. Nutrients. 2021 Feb 28;13(3):803. doi: 10.3390/nu13030803. PMID: 33671099; PMCID: PMC8000915.

Janitschke D, Lauer AA, Bachmann CM, Seyfried M, Grimm HS, Hartmann T, Grimm MOW. Unique Role of Caffeine Compared to Other Methylxanthines (Theobromine, Theophylline, Pentoxifylline, Propentofylline) in Regulation of AD Relevant Genes in Neuroblastoma SH-SY5Y Wild Type Cells. Int J Mol Sci. 2020 Nov 27;21(23):9015. doi: 10.3390/ijms21239015. PMID: 33260941; PMCID: PMC7730563.

Lauer AA, Mett J, Janitschke D, Thiel A, Stahlmann CP, Bachmann CM, Ritzmann F, Schrul B, Müller UC, Stein R, Riemenschneider M, Grimm HS, Hartmann T, Grimm MOW. Regulatory feedback cycle of the insulin-degrading enzyme and the amyloid precursor protein intracellular domain: Implications for Alzheimer’s disease. Aging Cell. 2020 Nov;19(11):e13264. doi: 10.1111/acel.13264. Epub 2020 Oct 31. PMID: 33128835; PMCID: PMC7681056.

Grimm MOW, Blümel T, Lauer AA, Janitschke D, Stahlmann C, Mett J, Haupenthal VJ, Miederer AM, Niemeyer BA, Grimm HS, Hartmann T. The impact of capsaicinoids on APP processing in Alzheimer’s disease in SH-SY5Y cells. Sci Rep. 2020 Jun 8;10(1):9164. doi: 10.1038/s41598-020-66009-6. PMID: 32514053; PMCID: PMC7280252.

Janitschke D, Nelke C, Lauer AA, Regner L, Winkler J, Thiel A, Grimm HS, Hartmann T, Grimm MOW. Effect of Caffeine and Other Methylxanthines on Aβ-Homeostasis in SH-SY5Y Cells. Biomolecules. 2019 Nov 2;9(11):689. doi: 10.3390/biom9110689. PMID: 31684105; PMCID: PMC6920871.

Grimm MOW, Lauer AA, Grösgen S, Thiel A, Lehmann J, Winkler J, Janitschke D, Herr C, Beisswenger C, Bals R, Grimm HS, Hartmann T. Profiling of Alzheimer’s disease related genes in mild to moderate vitamin D hypovitaminosis. J Nutr Biochem. 2019 May;67:123-137. doi: 10.1016/j.jnutbio.2019.01.015. Epub 2019 Feb PMID: 30889441.

Reinhardt S, Schuck F, Stoye N, Hartmann T, Grimm MOW, Pflugfelder G, Endres Transcriptional repression of the ectodomain sheddase ADAM10 by TBX2 and potential implication for Alzheimer’s disease. Cell Mol Life Sci. 2019 Mar;76(5):1005-1025. doi: 10.1007/s00018-018-2998-2. Epub 2019 Jan 1. PMID: 30599067.

Verheijen BM, Stevens JAA, Gentier RJG, van ‚t Hekke CD, van den Hove DLA, Hermes DJHP, Steinbusch HWM, Ruijter JM, Grimm MOW, Haupenthal VJ, Annaert W, Hartmann T, van Leeuwen FW. Paradoxical effects of mutant ubiquitin on Aβ plaque formation in an Alzheimer mouse model. Neurobiol Aging. 2018 Dec;72:62-71. doi: 10.1016/j.neurobiolaging.2018.08.011. Epub 2018 Aug 18. PMID: 30216939.

Grimm MOW, Thiel A, Lauer AA, Winkler J, Lehmann J, Regner L, Nelke C, Janitschke D, Benoist C, Streidenberger O, Stötzel H, Endres K, Herr C, Beisswenger C, Grimm HS, Bals R, Lammert F, Hartmann T. Vitamin D and Its Analogues Decrease Amyloid-β (Aβ) Formation and Increase Aβ-Degradation. Int J Mol Sci. 2017 Dec 19;18(12):2764. doi: 10.3390/ijms18122764. PMID: 29257109; PMCID: PMC5751363.

Grimm MOW, Michaelson DM, Hartmann T. Omega-3 fatty acids, lipids, and apoE lipidation in Alzheimer’s disease: a rationale for multi-nutrient dementia prevention. J Lipid Res. 2017 Nov;58(11):2083-2101. doi: 10.1194/jlr.R076331. Epub 2017 May 20. PMID: 28528321; PMCID: PMC5665674.

Grimm MO, Mett J, Grimm HS, Hartmann T. APP Function and Lipids: A Bidirectional Link. Front Mol Neurosci. 2017 Mar 10;10:63. doi: 10.3389/fnmol.2017.00063. PMID: 28344547; PMCID: PMC5344993.

Grimm MO, Mett J, Stahlmann CP, Haupenthal VJ, Blümel T, Stötzel H, Grimm HS, Hartmann T. Eicosapentaenoic acid and docosahexaenoic acid increase the degradation of amyloid-β by affecting insulin-degrading enzyme. Biochem Cell Biol. 2016 Dec;94(6):534-542. doi: 10.1139/bcb-2015-0149. Epub 2016 Apr 4. PMID: 27813426.

Grimm MO, Regner L, Mett J, Stahlmann CP, Schorr P, Nelke C, Streidenberger O, Stoetzel H, Winkler J, Zaidan SR, Thiel A, Endres K, Grimm HS, Volmer DA, Hartmann T. Tocotrienol Affects Oxidative Stress, Cholesterol Homeostasis and the Amyloidogenic Pathway in Neuroblastoma Cells: Consequences for Alzheimer’s Disease. Int J Mol Sci. 2016 Oct 29;17(11):1809. doi: 10.3390/ijms17111809. PMID: 27801864; PMCID: PMC5133810.

Grimm MO, Mett J, Hartmann T. The Impact of Vitamin E and Other Fat-Soluble Vitamins on Alzheimer´s Disease. Int J Mol Sci. 2016 Oct 26;17(11):1785. doi: 10.3390/ijms17111785. PMID: 27792188; PMCID: PMC5133786.

Wittmann A, Grimm MO, Scherthan H, Horsch M, Beckers J, Fuchs H, Gailus- Durner V, Hrabě de Angelis M, Ford SJ, Burton NC, Razansky D, Trümbach D, Aichler M, Walch AK, Calzada-Wack J, Neff F, Wurst W, Hartmann T, Floss T. Sphingomyelin Synthase 1 Is Essential for Male Fertility in Mice. PLoS One. 2016 Oct 27;11(10):e0164298. doi: 10.1371/journal.pone.0164298. PMID: 27788151; PMCID: PMC5082796.

Reinhardt S, Grimm MO, Stahlmann C, Hartmann T, Shudo K, Tomita T, Endres K. Rescue of Hypovitaminosis A Induces Non-Amyloidogenic Amyloid Precursor Protein (APP) Processing. Curr Alzheimer Res. 2016;13(11):1277-1289. doi: 10.2174/1567205013666160603002105. PMID: 27335034.

Grimm MO, Haupenthal VJ, Mett J, Stahlmann CP, Blümel T, Mylonas NT, Endres K, Grimm HS, Hartmann T. Oxidized Docosahexaenoic Acid Species and Lipid Peroxidation Products Increase Amyloidogenic Amyloid Precursor Protein Processing. Neurodegener Dis. 2016;16(1-2):44-54. doi: 10.1159/000440839. PMID: 26642316.

Grimm MO, Mett J, Stahlmann CP, Grösgen S, Haupenthal VJ, Blümel T, Hundsdörfer B, Zimmer VC, Mylonas NT, Tanila H, Müller U, Grimm HS, Hartmann T. APP intracellular domain derived from amyloidogenic β- and γ-secretase cleavage regulates neprilysin expression. Front Aging Neurosci. 2015 May 19;7:77. doi: 10.3389/fnagi.2015.00077. PMID: 26074811; PMCID: PMC4443740.

Grimm MO, Stahlmann CP, Mett J, Haupenthal VJ, Zimmer VC, Lehmann J, Hundsdörfer B, Endres K, Grimm HS, Hartmann T. Vitamin E: Curse or Benefit in Alzheimer’s Disease? A Systematic Investigation of the Impact of α-, γ- and δ-Tocopherol on Aß Generation and Degradation in Neuroblastoma Cells. J Nutr Health Aging. 2015 Jun;19(6):646-56. doi: 10.1007/s12603-015-0506-z. PMID: 26054501.

Blacher E, Dadali T, Bespalko A, Haupenthal VJ, Grimm MO, Hartmann T, Lund FE, Stein R, Levy A. Alzheimer’s disease pathology is attenuated in a CD38-deficient mouse model. Ann Neurol. 2015 Jul;78(1):88-103. doi: 10.1002/ana.24425. Epub 2015 May 25. PMID: 25893674; PMCID: PMC6929692.

Grimm MO, Hundsdörfer B, Grösgen S, Mett J, Zimmer VC, Stahlmann CP, Haupenthal VJ, Rothhaar TL, Lehmann J, Pätzold A, Zinser EG, Tanila H, Shen J, Müller U, Grimm HS, Hartmann T. PS dependent APP cleavage regulates glucosylceramide synthase and is affected in Alzheimer’s disease. Cell Physiol Biochem. 2014;34(1):92-110. doi: 10.1159/000362987. Epub 2014 Jun 16. PMID: 24977484.

Grimm MO, Zimmer VC, Lehmann J, Grimm HS, Hartmann T. The impact of cholesterol, DHA, and sphingolipids on Alzheimer’s disease. Biomed Res Int. 2013;2013:814390. doi: 10.1155/2013/814390. Epub 2014 Feb 19. PMID: 24575399; PMCID: PMC3929518.

Grimm MO, Mett J, Stahlmann CP, Haupenthal VJ, Zimmer VC, Hartmann T. Neprilysin and Aβ Clearance: Impact of the APP Intracellular Domain in NEP Regulation and Implications in Alzheimer’s Disease. Front Aging Neurosci. 2013 Dec 23;5:98. doi: 10.3389/fnagi.2013.00098. PMID: 24391587; PMCID: PMC3870290.

Robinson A, Grösgen S, Mett J, Zimmer VC, Haupenthal VJ, Hundsdörfer B, Stahlmann CP, Slobodskoy Y, Müller UC, Hartmann T, Stein R, Grimm MO. Upregulation of PGC-1α expression by Alzheimer’s disease-associated pathway: presenilin 1/amyloid precursor protein (APP)/intracellular domain of APP. Aging Cell. 2014 Apr;13(2):263-72. doi: 10.1111/acel.12183. Epub 2013 Dec 17. PMID: 24304563; PMCID: PMC4331788.

Grimm MO, Lehmann J, Mett J, Zimmer VC, Grösgen S, Stahlmann CP, Hundsdörfer B, Haupenthal VJ, Rothhaar TL, Herr C, Bals R, Grimm HS, Hartmann T. Impact of Vitamin D on amyloid precursor protein processing and amyloid-β peptide degradation in Alzheimer’s disease. Neurodegener Dis. 2014;13(2-3):75-81. doi: 10.1159/000355462. Epub 2013 Oct 30. PMID: 24192346.

Burg VK, Grimm HS, Rothhaar TL, Grösgen S, Hundsdörfer B, Haupenthal VJ, Zimmer VC, Mett J, Weingärtner O, Laufs U, Broersen LM, Tanila H, Vanmierlo T, Lütjohann D, Hartmann T, Grimm MO. Plant sterols the better cholesterol in Alzheimer’s disease? A mechanistical study. J Neurosci. 2013 Oct 9;33(41):16072-87. doi: 10.1523/JNEUROSCI.1506-13.2013. PMID: 24107941; PMCID: PMC6618349.

Grimm MO, Haupenthal VJ, Rothhaar TL, Zimmer VC, Grösgen S, Hundsdörfer B, Lehmann J, Grimm HS, Hartmann T. Effect of Different Phospholipids on α-Secretase Activity in the Non-Amyloidogenic Pathway of Alzheimer’s Disease. Int J Mol Sci. 2013 Mar 13;14(3):5879-98. doi: 10.3390/ijms14035879. PMID: 23485990; PMCID: PMC3634454.

Rothhaar TL, Grösgen S, Haupenthal VJ, Burg VK, Hundsdörfer B, Mett J, Riemenschneider M, Grimm HS, Hartmann T, Grimm MO. Plasmalogens inhibit APP processing by directly affecting γ-secretase activity in Alzheimer’s disease. ScientificWorldJournal. 2012;2012:141240. doi: 10.1100/2012/141240. Epub 2012 Apr 1. PMID: 22547976; PMCID: PMC3322458.

Grimm MO, Zinser EG, Grösgen S, Hundsdörfer B, Rothhaar TL, Burg VK, Kaestner L, Bayer TA, Lipp P, Müller U, Grimm HS, Hartmann T. Amyloid precursor protein (APP) mediated regulation of ganglioside homeostasis linking Alzheimer’s disease pathology with ganglioside metabolism. PLoS One. 2012;7(3):e34095. doi: 10.1371/journal.pone.0034095. Epub 2012 Mar 28. PMID: 22470521; PMCID: PMC3314703.

Grimm MO, Rothhaar TL, Grösgen S, Burg VK, Hundsdörfer B, Haupenthal VJ, Friess P, Kins S, Grimm HS, Hartmann T. Trans fatty acids enhance amyloidogenic processing of the Alzheimer amyloid precursor protein (APP). J Nutr Biochem. 2012 Oct;23(10):1214-23. doi: 10.1016/j.jnutbio.2011.06.015. Epub 2011 Dec 29. PMID: 22209004.

Grimm MO, Rothhaar TL, Hartmann T. The role of APP proteolytic processing in lipid metabolism. Exp Brain Res. 2012 Apr;217(3-4):365-75. doi: 10.1007/s00221-011-2975-6. Epub 2011 Dec 17. PMID: 22179528.

Grimm MO, Grösgen S, Riemenschneider M, Tanila H, Grimm HS, Hartmann T. From brain to food: analysis of phosphatidylcholins, lyso-phosphatidylcholins and phosphatidylcholin-plasmalogens derivates in Alzheimer’s disease human post mortem brains and mice model via mass spectrometry. J Chromatogr A. 2011 Oct 21;1218(42):7713-22. doi: 10.1016/j.chroma.2011.07.073. Epub 2011 Jul 30. PMID: 21872257.

Grimm MO, Grösgen S, Rothhaar TL, Burg VK, Hundsdörfer B, Haupenthal VJ, Friess P, Müller U, Fassbender K, Riemenschneider M, Grimm HS, Hartmann T. Intracellular APP Domain Regulates Serine-Palmitoyl-CoA Transferase Expression and Is Affected in Alzheimer’s Disease. Int J Alzheimers Dis. 2011;2011:695413. doi: 10.4061/2011/695413. Epub 2011 May 18. PMID: 21660213; PMCID: PMC3109855.

Grimm MO, Kuchenbecker J, Grösgen S, Burg VK, Hundsdörfer B, Rothhaar TL, Friess P, de Wilde MC, Broersen LM, Penke B, Péter M, Vígh L, Grimm HS, Hartmann Docosahexaenoic acid reduces amyloid beta production via multiple pleiotropic mechanisms. J Biol Chem. 2011 Apr 22;286(16):14028-39. doi: 10.1074/jbc.M110.182329. Epub 2011 Feb 15. PMID: 21324907; PMCID: PMC3077603.

Grimm MO, Kuchenbecker J, Rothhaar TL, Grösgen S, Hundsdörfer B, Burg VK, Friess P, Müller U, Grimm HS, Riemenschneider M, Hartmann T. Plasmalogen synthesis is regulated via alkyl-dihydroxyacetonephosphate-synthase by amyloid precursor protein processing and is affected in Alzheimer’s disease. J Neurochem. 2011 Mar;116(5):916-25. doi: 10.1111/j.1471-4159.2010.07070.x. Epub 2011 Jan 12. PMID: 21214572.

Grösgen S, Grimm MO, Friess P, Hartmann T. Role of amyloid beta in lipid homeostasis. Biochim Biophys Acta. 2010 Aug;1801(8):966-74. doi: 10.1016/j.bbalip.2010.05.002. Epub 2010 May 7. PMID: 20452461.

Grimm MO, Grimm HS, Tomic I, Beyreuther K, Hartmann T, Bergmann C. Independent inhibition of Alzheimer disease beta- and gamma-secretase cleavage by lowered cholesterol levels. J Biol Chem. 2008 Apr 25;283(17):11302-11. doi: 10.1074/jbc.M801520200. Epub 2008 Feb 28. PMID: 18308724.

Hartmann T, Kuchenbecker J, Grimm MO. Alzheimer’s disease: the lipid connection. J Neurochem. 2007 Nov;103 Suppl 1:159-70. doi: 10.1111/j.1471-4159.2007.04715.x. PMID: 17986151.

Grimm MO, Grimm HS, Hartmann T. Amyloid beta as a regulator of lipid homeostasis. Trends Mol Med. 2007 Aug;13(8):337-44. doi: 10.1016/j.molmed.2007.06.004. Epub 2007 Jul 17. PMID: 17644432.

Zinser EG, Hartmann T, Grimm MO. Amyloid beta-protein and lipid metabolism. Biochim Biophys Acta. 2007 Aug;1768(8):1991-2001. doi: 10.1016/j.bbamem.2007.02.014. Epub 2007 Feb 24. PMID: 17418089.

Grimm MO, Tschäpe JA, Grimm HS, Zinser EG, Hartmann T. Altered membrane fluidity and lipid raft composition in presenilin-deficient cells. Acta Neurol Scand Suppl. 2006;185:27-32. doi: 10.1111/j.1600-0404.2006.00682.x. PMID: 16866908.

Grimm MO, Grimm HS, Pätzold AJ, Zinser EG, Halonen R, Duering M, Tschäpe JA, De Strooper B, Müller U, Shen J, Hartmann T. Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin. Nat Cell Biol. 2005 Nov;7(11):1118-23. doi: 10.1038/ncb1313. Erratum in: Nat Cell Biol. 2006 Apr;8(4):424. PMID: 16227967.

Duering M, Grimm MO, Grimm HS, Schröder J, Hartmann T. Mean age of onset in familial Alzheimer’s disease is determined by amyloid beta 42. Neurobiol Aging. 2005 Jun;26(6):785-8. doi: 10.1016/j.neurobiolaging.2004.08.002. PMID: 15718035.

Grziwa B, Grimm MO, Masters CL, Beyreuther K, Hartmann T, Lichtenthaler SF. The transmembrane domain of the amyloid precursor protein in microsomal membranes is on both sides shorter than predicted. J Biol Chem. 2003 Feb 28;278(9):6803-8. doi: 10.1074/jbc.M210047200. Epub 2002 Nov 25. PMID: 12454010.

Grimm MO, Tomic I, Hartmann T. Potential external source of A beta in biological samples. Nat Cell Biol. 2002 Jul;4(7):E164-5; author reply E165-6. doi: 10.1038/ncb0702-e164b. PMID: 12105422.